NOVO-FLUVOXAMINE DIN 02239953
Health Canada record
| Active ingredient(s) | FLUVOXAMINE MALEATE 50 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N06AB08 FLUVOXAMINE |
| Original market date | 30-Apr-1999 |
| Current status date | 17-May-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLUVOXAMINE MALEATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02231329 | APO-FLUVOXAMINE | APOTEX INC | Tablet | FLUVOXAMINE MALEATE 50 MG | Marketed |
| 02231330 | APO-FLUVOXAMINE | APOTEX INC | Tablet | FLUVOXAMINE MALEATE 100 MG | Marketed |
| 02231192 | FLUVOXAMINE | APOTEX INC | Tablet | FLUVOXAMINE MALEATE 50 MG | Approved |
| 02231193 | FLUVOXAMINE | APOTEX INC | Tablet | FLUVOXAMINE MALEATE 100 MG | Approved |
| 01919369 | LUVOX | BGP PHARMA ULC | Tablet | FLUVOXAMINE MALEATE 100 MG | Marketed |
| 01919342 | LUVOX | BGP PHARMA ULC | Tablet | FLUVOXAMINE MALEATE 50 MG | Marketed |
| 02255529 | TEVA-FLUVOXAMINE | TEVA CANADA LIMITED | Tablet | FLUVOXAMINE MALEATE 50 MG | Marketed |
| 02255537 | TEVA-FLUVOXAMINE | TEVA CANADA LIMITED | Tablet | FLUVOXAMINE MALEATE 100 MG | Marketed |
| 02363771 | AVA-FLUVOXAMINE | AVANSTRA INC | Tablet | FLUVOXAMINE MALEATE 100 MG | Cancelled Post Market |
| 02363763 | AVA-FLUVOXAMINE | AVANSTRA INC | Tablet | FLUVOXAMINE MALEATE 50 MG | Cancelled Post Market |
| 02257688 | BCI FLUVOXAMINE TABLETS | BAKER CUMMINS INC | Tablet | FLUVOXAMINE MALEATE 100.0 MG | Cancelled Post Market |
| 02257661 | BCI FLUVOXAMINE TABLETS | BAKER CUMMINS INC | Tablet | FLUVOXAMINE MALEATE 50.0 MG | Cancelled Post Market |
| 02241347 | DOM-FLUVOXAMINE | DOMINION PHARMACAL | Tablet | FLUVOXAMINE MALEATE 50 MG | Cancelled Post Market |
| 02241348 | DOM-FLUVOXAMINE | DOMINION PHARMACAL | Tablet | FLUVOXAMINE MALEATE 100 MG | Cancelled Post Market |
| 02246823 | FLUVOXAMINE TABLETS | TEVA CANADA LIMITED | Tablet | FLUVOXAMINE MALEATE 100 MG | Cancelled Pre Market |
| 02246822 | FLUVOXAMINE TABLETS | TEVA CANADA LIMITED | Tablet | FLUVOXAMINE MALEATE 50 MG | Cancelled Pre Market |
| 02236754 | FLUVOXAMINE-100 | PRO DOC LIMITEE | Tablet | FLUVOXAMINE MALEATE 100 MG | Cancelled Post Market |
| 02236753 | FLUVOXAMINE-50 | PRO DOC LIMITEE | Tablet | FLUVOXAMINE MALEATE 50 MG | Cancelled Post Market |
| 02240850 | GEN-FLUVOXAMINE 100MG | GENPHARM ULC | Tablet | FLUVOXAMINE MALEATE 100 MG | Cancelled Post Market |
| 02240849 | GEN-FLUVOXAMINE 50MG | GENPHARM ULC | Tablet | FLUVOXAMINE MALEATE 50 MG | Cancelled Post Market |
| 02239954 | NOVO-FLUVOXAMINE | TEVA CANADA LIMITED | Tablet | FLUVOXAMINE MALEATE 100 MG | Cancelled Post Market |
| 02262622 | PHL-FLUVOXAMINE | PHARMEL INC | Tablet | FLUVOXAMINE MALEATE 50 MG | Cancelled Post Market |
| 02262630 | PHL-FLUVOXAMINE | PHARMEL INC | Tablet | FLUVOXAMINE MALEATE 100 MG | Cancelled Post Market |
| 02240682 | PMS-FLUVOXAMINE | PHARMASCIENCE INC | Tablet | FLUVOXAMINE MALEATE 50 MG | Cancelled Post Market |
| 02240683 | PMS-FLUVOXAMINE | PHARMASCIENCE INC | Tablet | FLUVOXAMINE MALEATE 100 MG | Cancelled Post Market |
| 02218453 | RATIO-FLUVOXAMINE | TEVA CANADA LIMITED | Tablet | FLUVOXAMINE MALEATE 50 MG | Cancelled Post Market |
| 02218461 | RATIO-FLUVOXAMINE | TEVA CANADA LIMITED | Tablet | FLUVOXAMINE MALEATE 100 MG | Cancelled Post Market |
| 02303345 | RIVA-FLUVOX | LABORATOIRE RIVA INC. | Tablet | FLUVOXAMINE MALEATE 50 MG | Cancelled Post Market |
| 02303361 | RIVA-FLUVOX | LABORATOIRE RIVA INC. | Tablet | FLUVOXAMINE MALEATE 100 MG | Cancelled Post Market |
| 02240724 | RIVA-FLUVOX 100MG TABLETS | LABORATOIRE RIVA INC. | Tablet | FLUVOXAMINE MALEATE 100 MG | Cancelled Post Market |
| 02240723 | RIVA-FLUVOX 50MG TABLETS | LABORATOIRE RIVA INC. | Tablet | FLUVOXAMINE MALEATE 50 MG | Cancelled Post Market |
| 02247054 | SANDOZ FLUVOXAMINE | SANDOZ CANADA INCORPORATED | Tablet | FLUVOXAMINE MALEATE 50 MG | Cancelled Post Market |
| 02247055 | SANDOZ FLUVOXAMINE | SANDOZ CANADA INCORPORATED | Tablet | FLUVOXAMINE MALEATE 100 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 15726 | 2014-06-17 | Abbreviated New Drug Submission (ANDS) | MANUFACTURER NAME CHANGE |
| 1819 | 1999-04-15 | Abbreviated New Drug Submission (ANDS) |
International API supply for FLUVOXAMINE MALEATE
2 valid EDQM Certificates of Suitability from 2 holders. 12 active FDA Drug Master Files.
Request a quote for NOVO-FLUVOXAMINE